(Q28216633)
Statements
Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer (English)
0 references
1 June 2002
0 references
99
0 references
4
0 references
579-82
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference